Found 6 matching trials
Receptor Occupancy of LB-102 Using Positron Emission Tomography (PET) in Healthy Volunteers
PHASE1This is an open label study in 4 cohort of 4 healthy volunteers each design...
Location
Washington University School of Medicine
Safety and Tolerability of Single and Multiple Doses of LB-102 in Healthy Adults
PHASE1A Single Ascending Dose (SAD; Part A) and Multiple Ascending Dose (MAD; Par...
Location
Medpace Clinical Pharmacology LLC
52-week Open Label Safety-Tolerability Study
PHASE3Phase 3, open label, multicenter study designed to assess the long term saf...
Location
Chandler Clinical Trials
Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia
PHASE2This is a Phase 2, randomized, double-blind, placebo-controlled, multi-cent...
Location
Pillar Clinical Research
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
PHASE2Phase II study for patients with Bipolar 1 Disorder experiencing major depr...
Location
Pillar Clinical Research
Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
PHASE3This is a Phase 3, randomized, double blind, placebo controlled, fixed dose...
Location
Pillar Clinical Research